| Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells S Ma, RF Dielschneider, ES Henson, W Xiao, TR Choquette, ... PLoS One 12 (8), e0182921, 2017 | 187 | 2017 |
| Lysosomes as oxidative targets for cancer therapy RF Dielschneider, ES Henson, SB Gibson Oxidative medicine and cellular longevity 2017 (1), 3749157, 2017 | 129 | 2017 |
| Multifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulation S Gujar, R Dielschneider, D Clements, E Helson, M Shmulevitz, ... Molecular Therapy 21 (2), 338-347, 2013 | 84 | 2013 |
| Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms SA Gujar, D Clements, R Dielschneider, E Helson, P Marcato, PWK Lee British journal of cancer 110 (1), 83-93, 2014 | 77 | 2014 |
| Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism RF Dielschneider, H Eisenstat, S Mi, JM Curtis, W Xiao, JB Johnston, ... Leukemia 30 (6), 1290-1300, 2016 | 47 | 2016 |
| Antimalarial drugs trigger lysosome-mediated cell death in chronic lymphocytic leukemia (CLL) cells S Das, R Dielschneider, A Chanas-LaRue, JB Johnston, SB Gibson Leukemia research 70, 79-86, 2018 | 24 | 2018 |
| Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling RF Dielschneider, W Xiao, JY Yoon, E Noh, V Banerji, H Li, AJ Marshall, ... Cell death & disease 5 (10), e1439-e1439, 2014 | 22 | 2014 |
| An LC/MS/MS method for the simultaneous determination of individual sphingolipid species in B cells S Mi, YY Zhao, RF Dielschneider, SB Gibson, JM Curtis Journal of Chromatography B 1031, 50-60, 2016 | 21 | 2016 |
| Vaccine Hesitancy: Christian Reasons and Responses. R Dielschneider Perspectives on Science & Christian Faith 73 (1), 2021 | 9 | 2021 |
| Lysosome membrane Permeabilization causes cell death in primary chronic lymphocytic leukemia cells R Dielschneider, H Eisenstat, JB Johnston, SB Gibson Blood 124 (21), 930, 2014 | 2 | 2014 |
| Antimalarial drugs trigger lysosome-mediated cell death in chronic lymphocytic leukemia (CLL) cells. SD Subhadip Das, R Dielschneider, A Chanas-LaRue, JB Johnston, ... | | 2018 |
| ZAP70 alters metabolism in chronic lymphocytic leukemic cells S Das, RF Dielschneider, ES Henson, SB Gibson Cancer Research 77 (13_Supplement), 5423-5423, 2017 | | 2017 |
| The Truth About Science and Religion: From the Big Bang to Neuroscience R Dielschneider Perspectives on Science and Christian Faith 69 (1), 63-65, 2017 | | 2017 |
| Targeting Susceptible Signaling Pathways in Chronic Lymphocytic Leukemia R Dielschneider University of Manitoba, 2016 | | 2016 |
| Tyrosine kinase inhibitor Gefitinib selectivley induces apoptosis in Zap70+ chronic lymphocytic leukemia cells and inhibits B cell receptor signaling. R Dielschneider, W Xiao, JY Yoon, E Noh, JB Johnston, SB Gibson Cancer Research 73 (8_Supplement), 911-911, 2013 | | 2013 |
